ROCKVILLE, MD — April 13 2021 — Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is collaborating with Swift Biosciences (now part of Integrated DNA Technologies), a pioneer in the development of research-use-only library preparation kits, to offer comprehensive SARS-CoV-2 variant determination using next-generation sequencing (NGS). Early in the pandemic, public health […]
ROCKVILLE, MD — February 23, 2021 — Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is proud to expand its next-generation sequencing capabilities to include end-to-end single cell sequencing (SCS) services. These services, which include gene expression and single cell immune profiling, are powered by the Chromium platform and Next GEM-based technology […]
As one of the newest members of the COVID-19 Testing Industry Consortium, we wanted to share with you the results of our Back-to-Work survey. The survey, conducted last fall, represents the experiences of 77 organizations across the United States. We hope the information inside will help us understand the intricacies of the ongoing pandemic challenges […]
We are proud to share the many number of valuable publications that we have released over the years. Feel free to read below to see what we have been working on and discovering since 2004. 2016 Jeong-Sun Seo et al. De novo assembly and phasing of a Korean human genome. Nature 538, 243-247 (2016). 2012 […]
We are proud to support the Sturge-Weber Foundation. Please watch this video to learn more about our partnership with them!
New Company Name Combines Mind, Body, and Genomics ROCKVILLE, MD — June 9, 2019 — Macrogen Corporation, a bioscience research firm that provides advanced research and clinical DNA sequencing services to U.S., recently announced a company name change. Macrogen Corp. is now officially Psomagen Inc: Humanizing Phenomics 120. Learn about Psomagen, Inc.:Psomagen.com “Macrogen has […]
Introduction Interdisciplinary efforts over several decades have provided intriguing information regarding the factors that contribute to racial differences in health status and outcomes. Even with this information on hand, challenges remain regarding improved characterization of these various biological and environmental factors. Advances in genomic studies have provided some of the valuable tools and data needed […]
Introduction A Centers for Disease Control website provides a definition for life expectancy as “the average number of years that a hypothetical group of infants would live at each attained age if the group was subject, throughout its lifetime, to the age-specific death rates prevailing for the actual population in a given year” (1). It […]
Chromatin Immunoprecipitation sequencing (ChIP-Seq) determines DNA binding sites for particular proteins on a genome. Chromatin Immunoprecipitation assays have the ability to capture an image of specific protein to DNA interactions that are occurring in a system and process these interactions using quantitative polymerase chain reaction (qPCR), ChIP-chip, or next generation sequencing (NGS). When paired with […]
Introduction Eradication and prevention of infectious diseases are achieved most often via vaccination. The common or traditional vaccines are made using the actual pathogen material, such as modified live or killed (inactivated) viruses. The use of these types of vaccines is sometimes associated with serious side effects. For some infectious agents, it is often difficult […]
Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.